Interact to see
Advertisement
Advertisement
JRARX vs RGACX
JRARX vs RGACX Comparison
Open Charts JRARX vs RGACX
JRARX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
JRARX vs. RGACX commentary
Sep 10, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JRARX is a StrongBuy and RGACX is a StrongBuy.
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 353B vs. JRARX (28.3B). JRARX (0.00) and RGACX (0.00) have matching dividends . JRARX was incepted earlier than RGACX: JRARX (10 years) vs RGACX (24 years). JRARX (1.53) is less costly to investors than RGACX (0.93). JRARX (33.00) and RGACX (32.00) have comparable annual turnover. RGACX has a lower initial minimum investment than JRARX: RGACX (250) vs JRARX (2500). RGACX annual gain was more profitable for investors over the last year : 0.87 vs. JRARX (-3.98). JRARX return over 5 years is better than : 22.16 vs. RGACX (11.29).
| JRARX | RGACX | JRARX / RGACX | |
| Total Expense Ratio | 1.48 | 0.93 | 159% |
| Annual Report Gross Expense Ratio | 1.53 | 0.93 | 165% |
| Fund Existence | 10 years | 24 years | - |
| Gain YTD | 5.074 | 9.283 | 55% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 28.3B | 353B | 8% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -3.98 | 0.87 | -458% |
| Returns for 3 years | 47.84 | 41.63 | 115% |
| Returns for 5 years | 22.16 | 11.29 | 196% |
| Returns for 10 years | N/A | 101.73 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYCFX | 53.90 | N/A | N/A |
| Rydex Biotechnology C | |||
| FDTCX | 37.28 | N/A | N/A |
| Fidelity Advisor Diversified Stock C | |||
| VLACX | 142.54 | N/A | N/A |
| Vanguard MStar Large Cap Index Investor | |||
| CRIHX | 13.29 | N/A | N/A |
| CRM Long/Short Opportunities Instl | |||
| AVEEX | 18.29 | -0.06 | -0.33% |
| Avantis® Emerging Markets Equity Instl | |||